[1]
P. Thitfield, “Integrated Immunomodulation, Antifibrotic Pharmacology, and Patient-Centered Analgesia: Translational Insights from Dupilumab, Pirfenidone, Nintedanib, and Nitrous Oxide Across Immune-Mediated and Fibrotic Disorders”, fmspj, vol. 6, no. 03, pp. 10–14, Mar. 2026.